In this episode, Medicom’s correspondent covers the highlights from the Dutch Dermatology Days (DDD 2023), held in Ermelo, the Netherlands, from 09-10 March 2023.
The topics discussed are:
- The role of surgeons in stage I–II melanoma
- When to screen for anal intraepithelial neoplasia?
- Eligibility and selection of JAK inhibitors for constitutional eczema
- JAK inhibitors for alopecia areata
- OCT non-inferior to biopsy in BCC
- Scabies: therapy failure and tips for the clinic
Enjoy listening!
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« ACC 2023 Highlights Podcast Next Article
AAD 2023 Highlights Podcast »
« ACC 2023 Highlights Podcast Next Article
AAD 2023 Highlights Podcast »
Table of Contents: DDD 2023
Featured articles
Dermato-Oncology
The role of surgeons in stage I–II melanoma
Melanoma: Surveillance and follow-up
When to screen for anal intraepithelial neoplasia?
JAK Inhibitors
Eligibility and selection of JAK inhibitors for constitutional eczema
Nutrition and the Skin
Obesity and the skin: state of affairs
What's New?
The importance of anti-microbial proteins in the skin
OCT non-inferior to biopsy in basal cell carcinoma
Infections
Scabies: Therapy failure and tips for the clinic
Related Articles
May 10, 2023
Obesity and the skin: state of affairs
May 10, 2023
When to screen for anal intraepithelial neoplasia?
May 10, 2023
The rise of JAK inhibitors for alopecia areata
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com